Imbio PHA (4.0.0) vs BodyGuardian Remote Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Imbio PHA (4.0.0)

by Imbio (a subsidiary of 4DMedical)

BodyGuardian Remote Monitoring System

by Boston Scientific Cardiac Diagnostics

AI Verdict

Tool A specializes in AI-powered analysis of CT pulmonary angiogram scans to measure cardiac structures for conditions like pulmonary embolism and hypertension. In contrast, Tool B is a wearable system designed for continuous remote monitoring of ambulatory patients to detect non-lethal cardiac arrhythmias. While both utilize AI in cardiology, their differing data sources (imaging versus physiological signals) and primary clinical applications make them distinct, serving different diagnostic and monitoring needs.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if you need rapid, AI-powered analysis of existing CT pulmonary angiogram (CTPA) scans to assess cardiac structures. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by automatically measuring ventricular and pulmonary artery diameters and ratios.

View Imbio PHA (4.0.0) →

Choose BodyGuardian Remote Monitoring System if…

Choose BodyGuardian Remote Monitoring System if you require continuous, long-term physiological data collection for ambulatory patients. This wearable device is best suited for detecting and monitoring non-lethal cardiac arrhythmias, providing comprehensive data on ECG, heart rate, and activity levels through a combined mobile cardiac telemetry, event, and Holter monitoring approach.

View BodyGuardian Remote Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Imbio PHA (4.0.0)	BodyGuardian Remote Monitoring System
Deployment	Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).	Cloud-based platform with EMR integration.
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio PHA (4.0.0)

Imbio PHA integrates seamlessly into existing radiology workflows by generating annotated DICOM images and PDF reports, and offers rapid, fully-automated assessments. This focus on integration with native DICOM tools and quick processing streamlines the clinical user's experience within their established environment.

Clinical Value

BodyGuardian Remote Monitoring System

Both tools are FDA-cleared and provide significant clinical value. However, BodyGuardian offers continuous, ambulatory monitoring for non-lethal cardiac arrhythmias, combining multiple monitoring technologies (MCT, event, Holter) into a single wearable device. This comprehensive, long-term data collection, powered by BeatLogic deep learning AI, provides a broader scope for diagnosing and managing intermittent cardiac rhythm disorders.

Pricing & Value

Tie

Neither Imbio PHA nor BodyGuardian Remote Monitoring System provides publicly available pricing information. Both require direct contact with the vendor for pricing details, making a direct comparison of their pricing and overall value impossible without further information.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA offers more flexible deployment options, including Cloud, Enterprise (on-premise), or via partners, which caters to diverse IT infrastructures and security requirements. Additionally, its HIPAA compliance is explicitly third-party certified by Compliancy Group, providing an extra layer of assurance for enterprise adoption.

Innovation

BodyGuardian Remote Monitoring System

While both leverage AI, BodyGuardian Remote Monitoring System demonstrates greater innovation by integrating multiple cardiac monitoring modalities (mobile cardiac telemetry, event monitoring, and Holter monitoring) into a single wearable device. This, combined with wireless data transmission and sophisticated BeatLogic deep learning AI, offers a more comprehensive and convenient solution for ambulatory cardiac monitoring.

Support & Docs

Tie

The provided information for both tools does not detail their specific support offerings or documentation availability. While Imbio mentions a 'Support Portal' and Boston Scientific (Preventice) is a large company with expected robust support, there isn't enough comparative detail to definitively choose a winner for this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Imbio PHA (4.0.0)	BodyGuardian Remote Monitoring System
Name	Imbio PHA (4.0.0)	BodyGuardian Remote Monitoring System
Company	Imbio	Preventice Technologies (now Boston Scientific Cardiac Diagnostics)
Description	FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.	A wearable device that collects and transmits physiological data for the detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients, integrating multiple monitoring technologies and AI-powered analytics.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Pediatrics
Key Features (Summary)	Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters; calculates RV/LV and PA/Ao ratios; generates annotated DICOM images and PDF reports.	Wearable body sensor for continuous cardiac monitoring; detects and monitors non-lethal cardiac arrhythmias; collects ECG, heart rate, respiration rate, and activity level data; wireless data transmission to a cloud-based platform.

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and BodyGuardian Remote Monitoring System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for each tool?

Imbio PHA (4.0.0) is an AI-powered software designed to measure cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. The BodyGuardian Remote Monitoring System is a wearable device that collects and transmits physiological data to detect and monitor non-lethal cardiac arrhythmias in ambulatory patients.

What type of patient data does each system utilize and how is it acquired?

Imbio PHA (4.0.0) processes medical image data specifically from CT pulmonary angiogram (CTPA) scans. The BodyGuardian Remote Monitoring System collects physiological data such as ECG, heart rate, respiration rate, and activity level via a wearable body sensor. This data is then wirelessly transmitted via a mobile phone to a cloud-based platform.

How do the AI capabilities of each tool differ in their function?

Imbio PHA (4.0.0) utilizes artificial intelligence algorithms for anatomical identification and automated measurement of cardiac structures like right and left ventricle diameters, and main pulmonary artery and aorta diameters. In contrast, the BodyGuardian Remote Monitoring System employs sophisticated algorithms, including BeatLogic deep learning AI, for accurate rhythm analysis to detect and monitor cardiac arrhythmias.

What kind of output or reports can I expect from each tool to aid in diagnosis and patient management?

Imbio PHA (4.0.0) generates annotated DICOM images and provides summary reports in PDF format, including calculated RV/LV and PA/Ao ratios. The BodyGuardian Remote Monitoring System transmits collected physiological data to a cloud-based platform for physician review, providing insights for the detection and monitoring of non-lethal cardiac arrhythmias. Clinicians receive comprehensive diagnostic reports backed by advanced rhythm analytics.

Which patient populations or conditions are each tool best suited for?

Imbio PHA (4.0.0) is best suited for patients undergoing CT pulmonary angiogram (CTPA) scans to assess for right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. The BodyGuardian Remote Monitoring System is designed for ambulatory adult and pediatric patients (at least 29 days old) for the detection and monitoring of non-lethal cardiac arrhythmias.

Does either tool involve direct patient interaction or a wearable component?

Imbio PHA (4.0.0) is a software for medical image processing and does not involve direct patient interaction or a wearable component. The BodyGuardian Remote Monitoring System, however, is a wearable device that patients wear on their body for continuous cardiac monitoring.